Atopic Dermatitis Global Clinical Trials Review, H1, 2013
Summary
GlobalData's clinical trial report, "Atopic Dermatitis Global Clinical Trials Review, H1, 2013" provides data on the Atopic Dermatitis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Atopic Dermatitis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Atopic Dermatitis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
Understand the dynamics of a particular indication in a condensed manner
Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
Obtain discontinued trial listing for trials across the globe
Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents
TOC
Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 6
Introduction 7
Atopic Dermatitis 7
Report Guidance 7
Clinical Trials by Region 8
Clinical Trials by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by BRIC Nations 16
Clinical Trials by G7 Nations 17
Clinical Trials in G7 Nations by Trial Status 18
Clinical Trials by E7 Nations 19
Clinical Trials in E7 Nations by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Unaccomplished Trials of Atopic Dermatitis 24
Subjects Recruited Over a Period of Time 25
Prominent Sponsors 26
Top Companies Participating in Atopic Dermatitis Therapeutics Clinical Trials 28
Prominent Drug Comparison 30
Clinical Trial Profiles 31
Clinical Trial Overview of Top Companies 31
Astellas Pharma Inc. 31
Clinical Trial Overview of Astellas Pharma Inc. 31
Novartis AG 32
Clinical Trial Overview of Novartis AG 32
Maruho Co., Ltd. 34
Clinical Trial Overview of Maruho Co., Ltd. 34
LEO Pharma A/S 35
Clinical Trial Overview of LEO Pharma A/S 35
Laboratoires Pierre Fabre SA 36
Clinical Trial Overview of Laboratoires Pierre Fabre SA 36
Galderma S.A. 37
Clinical Trial Overview of Galderma S.A. 37
GlaxoSmithKline plc 38
Clinical Trial Overview of GlaxoSmithKline plc 38
Fougera Pharmaceuticals Inc. 39
Clinical Trial Overview of Fougera Pharmaceuticals Inc. 39
Shionogi & Co., Ltd. 40
Clinical Trial Overview of Shionogi & Co., Ltd. 40
Regeneron Pharmaceuticals, Inc. 41
Clinical Trial Overview of Regeneron Pharmaceuticals, Inc. 41
MIKA Pharma GmbH 42
Clinical Trial Overview of MIKA Pharma GmbH 42
Anacor Pharmaceuticals, Inc. 43
Clinical Trial Overview of Anacor Pharmaceuticals, Inc. 43
Intendis GmbH 44
Clinical Trial Overview of Intendis GmbH 44
Derm Research, PLLC 45
Clinical Trial Overview of Derm Research, PLLC 45
ALK-Abello A/S 46
Clinical Trial Overview of ALK-Abello A/S 46
Kaken Pharmaceutical Co., Ltd. 47
Clinical Trial Overview of Kaken Pharmaceutical Co., Ltd. 47
Bayer AG 48
Clinical Trial Overview of Bayer AG 48
Max Zeller Sohne AG 49
Clinical Trial Overview of Max Zeller Sohne AG 49
Orion Oyj 50
Clinical Trial Overview of Orion Oyj 50
Chugai Pharmaceutical Co., Ltd. 51
Clinical Trial Overview of Chugai Pharmaceutical Co., Ltd. 51
Clinical Trial Overview of Top Universities / Institutes / Hospitals 52
Wake Forest University 52
Clinical Trial Overview of Wake Forest University 52
Dresden University of Technology 53
Clinical Trial Overview of Dresden University of Technology 53
Oregon Health and Science University 54
Clinical Trial Overview of Oregon Health and Science University 54
University of California, Davis 55
Clinical Trial Overview of University of California, Davis 55
Hadassah Medical Organization 56
Clinical Trial Overview of Hadassah Medical Organization 56
Helsinki University Central Hospital 57
Clinical Trial Overview of Helsinki University Central Hospital 57
The Royal Children's Hospital 58
Clinical Trial Overview of The Royal Children's Hospital 58
Yokohama City University 59
Clinical Trial Overview of Yokohama City University 59
Children's Clinic Randers 60
Clinical Trial Overview of Children's Clinic Randers 60
Assistance Publique Hopitaux De Marseille 61
Clinical Trial Overview of Assistance Publique Hopitaux De Marseille 61
FUDAN University 62
Clinical Trial Overview of FUDAN University 62
Medical College of Wisconsin 63
Clinical Trial Overview of Medical College of Wisconsin 63
Tufts Medical Center 64
Clinical Trial Overview of Tufts Medical Center 64
Northwestern University 65
Clinical Trial Overview of Northwestern University 65
VU University Medical Center 66
Clinical Trial Overview of VU University Medical Center 66
Rockefeller University 67
Clinical Trial Overview of Rockefeller University 67
Kyoto University 68
Clinical Trial Overview of Kyoto University 68
University of Missouri 69
Clinical Trial Overview of University of Missouri 69
University of Michigan 70
Clinical Trial Overview of University of Michigan 70
UMC Utrecht Holding BV 71
Clinical Trial Overview of UMC Utrecht Holding BV 71
Atopic Dermatitis Global Clinical Trials Review, H1, 2013 published by GlobalData in January 31, 2013. This report consists of Pages: 92 and the price starts from US $ 2500.
The contents of this page may be different from the latest version. Please contact us for details.
